Tag: pharmaceuticals
-
Protein-Eluding Scaffolds Help Grow New Blood Vessels
A polymer frame infused with proteins that stimulate immune cells encourages growth of new blood vessels in lab mice with peripheral artery disease.
-
Once-a-Month Contraceptive Pill Being Developed
A company specializing in long-term release of drugs is receiving a foundation grant to develop a contraceptive pill for women that works for weeks at a time.
-
Hearing Loss Cell Therapy Licensed in $625M Deal
A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma.
-
Genentech, Biotech Partner on Multiple Sclerosis
A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech.
-
Trial to Test App Alerting for Dementia-Linked Drugs
A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer’s disease will soon be tested in a clinical trial.
-
Trial Shows Immunotherapies Extend Life with Melanoma
First results from a clinical trial show a combination of immunotherapies extends survival among patients with melanoma, but shorter periods for other solid-tumor cancers.
-
Crispr Enhanced for RNA Editing
Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases.
-
Analysis – Most New Drugs Not Adding Patient Benefits
An analysis of drugs approved for use in Germany since 2011 shows no evidence most treatments provide new or added benefits to patients compared to standard care.
-
Cold-Chain Drug Delivery Tested Via Drone
A group of companies and organizations designed and tested a long-distance drone capable of delivering drugs needing constant cold temperatures.
-
Voice Indicators to Monitor Dementia Progression
A company developing diagnostics for cognitive disorders from changes in speech patterns is partnering on vocal biomarkers to track progression of a form of dementia.